Associated Banc Corp Has $1.45 Million Stock Position in Roche Holding AG (OTCMKTS:RHHBY)

Associated Banc Corp decreased its position in Roche Holding AG (OTCMKTS:RHHBY) by 6.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,265 shares of the company’s stock after selling 3,075 shares during the period. Associated Banc Corp’s holdings in Roche were worth $1,454,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Hantz Financial Services Inc. raised its holdings in shares of Roche by 0.9% in the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock worth $1,176,000 after buying an additional 305 shares in the last quarter. Canopy Partners LLC raised its holdings in shares of Roche by 4.6% in the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after buying an additional 344 shares in the last quarter. Brooklyn Investment Group raised its holdings in shares of Roche by 36.6% in the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after buying an additional 363 shares in the last quarter. Altrius Capital Management Inc raised its holdings in shares of Roche by 0.3% in the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock worth $6,399,000 after buying an additional 603 shares in the last quarter. Finally, Diversified Trust Co raised its holdings in shares of Roche by 1.2% in the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after buying an additional 711 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a research report on Thursday, January 30th. UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Finally, Morgan Stanley assumed coverage on Roche in a research report on Wednesday, February 12th. They set an “equal weight” rating on the stock. Two research analysts have rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Roche Stock Up 0.9 %

Shares of RHHBY opened at $43.25 on Friday. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. The business’s fifty day moving average price is $39.81 and its two-hundred day moving average price is $38.53. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $43.96.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.